PTC Therapeutics, Inc. (PTCT)

NASDAQ: PTCT · Real-Time Price · USD

72.38

+0.61 (0.85%)

Nov 6, 2025, 10:09 AM EST - Market open

PTC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Nov '25 Nov 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	5,811	3,481	2,080	2,786	2,816	4,164	Upgrade
Market Cap Growth	96.53%	67.40%	-25.35%	-1.06%	-32.38%	40.68%	Upgrade
Enterprise Value	6,639	4,940	3,253	3,671	3,207	4,102	Upgrade
Last Close Price	71.77	45.14	27.56	38.17	39.83	61.03	Upgrade
PS Ratio	3.16	4.32	2.22	3.99	5.23	10.94	Upgrade
PB Ratio	-	-3.17	-2.54	-8.03	1958.20	8.64	Upgrade
EV/Sales Ratio	3.73	6.12	3.47	5.25	5.95	10.77	Upgrade
Debt / Equity Ratio	-16.00	-2.25	-2.72	-4.21	882.73	2.28	Upgrade
Asset Turnover	0.79	0.45	0.52	0.38	0.26	0.20	Upgrade
Inventory Turnover	11.39	22.02	27.95	36.97	33.17	23.33	Upgrade
Quick Ratio	2.21	2.26	1.90	1.39	1.74	4.23	Upgrade
Current Ratio	2.32	2.35	2.02	1.71	1.87	4.44	Upgrade
Return on Equity (ROE)	-	-	-	-	-216.75%	-81.42%	Upgrade
Return on Assets (ROA)	25.70%	-5.09%	-12.13%	-15.09%	-11.30%	-11.21%	Upgrade
Return on Capital (ROIC)	30.63%	-6.59%	-17.30%	-23.05%	-16.43%	-17.15%	Upgrade
Earnings Yield	12.84%	-10.44%	-30.13%	-20.06%	-18.61%	-10.52%	Upgrade
FCF Yield	12.05%	-3.28%	-8.98%	-13.95%	-9.93%	-5.09%	Upgrade
Buyback Yield / Dilution	-10.56%	-2.68%	-4.33%	-1.79%	-6.72%	-12.17%	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q